Could dexmedetomidine be repurposed as a glymphatic enhancer?
Persson NDÅ, Uusalo P, Nedergaard M, Lohela TJ, Lilius TO.
Trends Pharmacol Sci. 2022 Dec;43(12):1030-1040. doi: 10.1016/j.tips.2022.09.007. Epub 2022 Oct 21.
Hyperactive Delirium with Severe Agitation.
Springer B.
Emerg Med Clin North Am. 2024 Feb;42(1):41-52. doi: 10.1016/j.emc.2023.06.011. Epub 2023 Sep 21.
Procedural sedation and analgesia in children.
Krauss B, Green SM.
Lancet. 2006 Mar 4;367(9512):766-80. doi: 10.1016/S0140-6736(06)68230-5.
Dexmedetomidine: current role in anesthesia and intensive care.
Afonso J, Reis F.
Rev Bras Anestesiol. 2012 Jan-Feb;62(1):118-33. doi: 10.1016/S0034-7094(12)70110-1.
Remimazolam: A Review in Procedural Sedation.
Lee A, Shirley M.
Drugs. 2021 Jul;81(10):1193-1201. doi: 10.1007/s40265-021-01544-8. Epub 2021 Jul 1.
Remimazolam.
Teixeira MT, Goyal A.
Adv Anesth. 2024 Dec;42(1):131-150. doi: 10.1016/j.aan.2024.07.010.
Dexmedetomidine: A Review of Its Use for Sedation in the Intensive Care Setting.
Keating GM.
Drugs. 2015 Jul;75(10):1119-30. doi: 10.1007/s40265-015-0419-5.
Neonatal Abstinence Syndrome: Review of Epidemiology, Care Models, and Current Understanding of Outcomes.
MacMillan KDL.
Clin Perinatol. 2019 Dec;46(4):817-832. doi: 10.1016/j.clp.2019.08.012. Epub 2019 Aug 14.
International Analgesia and Sedation Weaning and Withdrawal Practices in Critically Ill Adults: The Adult Iatrogenic Withdrawal Study in the ICU.
Bolesta S, Burry L, Perreault MM, Gélinas C, Smith KE, Eadie R, Carini FC, Saltarelli K, Mitchell J, Harpel J, Stewart R, Riker RR, Fraser GL, Erstad BL; AduLt iatrogEnic withdRawal sTudy in the ICU (ALERT-ICU) Study Investigators.
Crit Care Med. 2023 Nov 1;51(11):1502-1514. doi: 10.1097/CCM.0000000000005951. Epub 2023 Jun 7.
Dexmedetomidine.
Coursin DB, Coursin DB, Maccioli GA.
Curr Opin Crit Care. 2001 Aug;7(4):221-6. doi: 10.1097/00075198-200108000-00002.
